Valuation: Prince Pharmaceutical Co., Ltd.

Market Cap 1.07B 33.35M 28.8M 27.07M 24.62M 46.28M 3.19B 47.04M 317M 124M 1.6B 125M 122M 5.31B P/E 2024
-15x
P/E 2025 11.9x
Enterprise Value 1.34B 41.77M 36.08M 33.9M 30.83M 57.96M 3.99B 58.92M 397M 155M 2B 157M 153M 6.65B EV / Sales 2024
1.68x
EV / Sales 2025 1.33x
Free-Float
42.7%
Yield 2024 *
-
Yield 2025 1.61%
1 day-3.64%
1 week-6.87%
Current month-1.85%
1 month-3.64%
3 months-3.80%
6 months-0.51%
Current year-6.27%
1 week 26.35
Extreme 26.35
31.5
1 month 26.35
Extreme 26.35
33.05
Current year 26.35
Extreme 26.35
33.05
1 year 24.9
Extreme 24.9
35.85
3 years 18.5
Extreme 18.5
40.9
5 years 18.5
Extreme 18.5
75.2
10 years 18.5
Extreme 18.5
75.2
Manager TitleAgeSince
Chief Executive Officer - 2021-12-09
Director of Finance/CFO - 2008-06-01
Chief Tech/Sci/R&D Officer - 1991-01-31
Director TitleAgeSince
Director/Board Member - 2023-01-17
Director/Board Member - 2023-01-17
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
-3.64%-6.87%+15.67%-25.26% 34.47M
-0.71%-7.85%+23.78%+72.25% 12.86B
-1.24%+1.92%-23.08%+297.11% 8.52B
+0.50%+0.30%-18.11%-49.80% 2.5B
-1.83%+15.99%-15.26%-15.35% 1.48B
-0.11%+0.29%+25.99%+69.68% 1.36B
-2.18%-11.23%-72.81%-71.19% 1.28B
+1.31%+7.12%+26.46%-28.60% 1.28B
-1.59%-8.90%-38.63% - 1.12B
+1.21%+1.94%-61.04%-69.26% 989M
Average -0.83%-1.73%-13.70%+19.95% 3.14B
Weighted average by Cap. -0.74%-3.96%-2.73%+105.98%

Financials

2024 2025
Net sales 690M 21.57M 18.63M 17.5M 15.92M 29.93M 2.06B 30.42M 205M 80.19M 1.03B 80.97M 79.21M 3.43B 1.06B 33.01M 28.51M 26.79M 24.37M 45.81M 3.16B 46.56M 314M 123M 1.58B 124M 121M 5.25B
Net income -53.54M -1.67M -1.45M -1.36M -1.24M -2.32M -160M -2.36M -15.91M -6.22M -80.13M -6.28M -6.15M -266M 96.32M 3.01M 2.6M 2.44M 2.22M 4.18M 288M 4.25M 28.63M 11.19M 144M 11.3M 11.06M 479M
Net Debt 358M 11.19M 9.66M 9.08M 8.26M 15.53M 1.07B 15.78M 106M 41.6M 536M 42.01M 41.1M 1.78B 269M 8.42M 7.27M 6.83M 6.22M 11.68M 805M 11.88M 80.07M 31.31M 403M 31.61M 30.93M 1.34B
Logo Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co Ltd is a Taiwan-based Company engaged in the manufacture and sale of health food and ingredients. The Company's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs. The health food business is mainly engaged in the original equipment manufacturer (OEM) and original design manufacturer (ODM) of health food products, providing a series of integrated services from product formulation design, research and development to the production and packaging of various dosage forms. The Company sells its products mainly in domestic and overseas markets, including Japan and Korea.
Employees
216
Date Price Change Volume
26-08-13 NT$29.15 -3.64% 42,820
26-08-13 NT$30.25 -3.51% 88,119
26-08-12 NT$31.35 +0.16% 21,030
26-08-11 NT$31.30 -0.16% 3,070
26-08-10 NT$31.35 -0.48% 24,117
  1. Stock Market
  2. Stocks
  3. 6935 Stock